Small Molecule Agonists for the Type I Interferon Receptor: An In Silico Approach
Small Molecule Agonists for the Type I Interferon Receptor: An In Silico Approach
About this item
Full title
Author / Creator
Publisher
United States: Mary Ann Liebert, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Mary Ann Liebert, Inc
Subjects
More information
Scope and Contents
Contents
Type I interferons (IFNs) exhibit broad-spectrum antiviral activity, with potential utility against emerging acute virus infections that pose a threat to global health. Recombinant IFN-αs that have been approved for clinical use require cold storage and are administered through intramuscular or subcutaneous injection, features that are problematic...
Alternative Titles
Full title
Small Molecule Agonists for the Type I Interferon Receptor: An In Silico Approach
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1776651175
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1776651175
Other Identifiers
ISSN
1079-9907
E-ISSN
1557-7465
DOI
10.1089/jir.2015.0123
